Jubilant Ingrevia Limited
₹559.05-₹8.90 (-1.6%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹10,899 Cr
- P/E
- 39.8x
- EV / EBITDA
- 26.2x
- Revenue
- ₹3,941 Cr
- Net margin
- 4.1%
- ROCE
- 13.1%
Price chart
Technical chartScreen technicals →-19.9% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -14.5%
- 3M
- -23.3%
- 6M
- -21.6%
- 1Y
- -19.9%
- 5Y
- -12.1%
52-week range
Day change -₹8.90 (-1.6%) from ₹568 to ₹559 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in JUBLINGREA, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Maintains healthy dividend payout of 49.0%
Concerns1
- Low return on equity of 7.2%
Rule-based from financial data. Not advice.
About the company
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates.
Read moreShow less
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
- Sector
- Materials
- Shares outstanding
- 15.9 Cr shares
- ISIN
- INE0BY001018
- BSE code
- 543271
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹10,899 Cr
- P/E
- 39.8x
- P/B
- 4.3x
- EV / EBITDA
- 26.2x
- EV / Sales
- 2.9x
- P/S
- 2.7x
- Earnings yield
- 2.5%
- 52-week high
- ₹764.25
- 52-week low
- ₹541.70
Profitability
- Operating margin
- 10.3%
- Net margin
- 4.1%
- EBITDA margin
- 11.0%
- ROE
- 7.2%
- ROCE
- 13.1%
- ROA
- 3.7%
- Dividend payout
- 49.0%
- Tax rate
- 32.0%
- Other income, % of PBT
- 12.1%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹3,941 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -1.2%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹438 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -16.7%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 62.3%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹394 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -11.7%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹22.0 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 6.9%
Solvency and efficiency
- Current ratio
- 1.53
- Debt / Equity
- 0.39
- Debt / Assets
- 0.20
- Debt / EBITDA
- 1.99
- Interest coverage
- 6.20
- Financial leverage
- 1.93
- CFO / Net profit
- 2.43
- Cash / Market cap
- 14.4%
- Cash per share
- ₹98.59
- Asset turnover
- 0.92
- Fixed asset turnover
- 1.74
- Capital intensity
- 0.57
- Debtor days
- 52 days
- Inventory turnover
- 2.77
- Cash conversion cycle
- 55 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹7 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹3,466 Cr |
| Sales | Operating profit | ₹475 Cr |
| Operating profit | Interest | ₹65 Cr |
| Operating profit | Depreciation | ₹147 Cr |
| Operating profit | Profit before tax | ₹263 Cr |
| Other income | Profit before tax | ₹81 Cr |
| Profit before tax | Tax and other | ₹80 Cr |
| Profit before tax | Net profit | ₹263 Cr |
Revenue and net profit
Revenue fell 1.2% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹669 Cr | ₹39 Cr |
| FY2022 | ₹4,860 Cr | ₹452 Cr |
| FY2023 | ₹4,560 Cr | ₹253 Cr |
| FY2024 | ₹3,987 Cr | ₹162 Cr |
| FY2025 | ₹3,941 Cr | ₹263 Cr |
Cash flows
FY2025: ₹441 Cr from operations, ₹230 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹104 Cr | ₹136 Cr |
| FY2022 | ₹587 Cr | ₹366 Cr |
| FY2023 | ₹446 Cr | -₹29 Cr |
| FY2024 | ₹394 Cr | -₹70 Cr |
| FY2025 | ₹441 Cr | ₹230 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹3,941 Cr-1.2%1Y
- Net profit
- ₹263 Cr+62.3%1Y
- Cash from operations
- ₹441 Cr
- Free cash flow
- ₹230 Cr
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹3,941 Cr | ₹475 Cr | — | ₹263 Cr | ₹441 Cr | ₹230 Cr | 10.8% | -1.2% | +62.3% |
Monthly returns
Month-by-month returns of JUBLINGREA across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹4,521 Cr |
| Equity capital | ₹16 Cr |
| Reserves | ₹2,425 Cr |
| Borrowings | ₹825 Cr |
| Other liabilities | ₹1,255 Cr |
| Assets | ₹4,521 Cr |
| Fixed assets | ₹2,335 Cr |
| Capital work in progress | ₹197 Cr |
| Investments | ₹310 Cr |
| Other assets | ₹1,679 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
JUBLINGREA trades at 39.8x earnings against a peer median of 35.5x (a 12% premium).
Not shown (no positive earnings and no EV / Sales): NMDC Steel Limited.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Jubilant Ingrevia LimitedJUBLINGREAthis companyP/E ↑ premium | ₹10,899 Cr | 39.8x | 4.3x | 7.2% | 26.2x |
| Fine Organic Industries LimitedFINEORG | ₹12,930 Cr | 35.8x | 5.5x | 19.8% | 22.8x |
| Nuvoco Vistas Corporation LimitedNUVOCO | ₹12,637 Cr | 64.8x | 1.4x | 1.7% | 12.5x |
| NMDC Steel LimitedNSLNISP | ₹12,244 Cr | — | 0.9x | -10.1% | -13.2x |
| GRAVITA INDIA LIMITEDGRAVITA | ₹11,994 Cr | 45.6x | 7.0x | 39.4% | 47.6x |
| PCBL Chemical LimitedPCBL | ₹11,042 Cr | 30.8x | 2.7x | 16.3% | 13.6x |
| Supreme Petrochem Ltd.SPLPETRO | ₹10,605 Cr | 34.5x | 4.8x | — | — |
| PRIVI SPECIALITY CHEMICALS LIMITEDPRIVISCL | ₹10,554 Cr | 37.8x | 8.4x | 10.7% | 32.1x |
| JK Lakshmi Cement LimitedJKLAKSHMI | ₹9,438 Cr | 20.4x | 2.5x | 14.9% | 9.9x |
| Peer median | — | 35.5x | 3.7x | 12.9% | 19.2x |
Year-to-date ROI
JUBLINGREA since 1 January, against earlier years.
Historical volatility
JUBLINGREA's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 14.0% |
| FY2022 | 17.0% |
| FY2023 | 11.0% |
| FY2024 | 10.0% |
| FY2025 | 12.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹3,941 Cr |
| Costs | |
| Interest | ₹65 Cr |
| Expenses | ₹3,466 Cr |
| Operating profitOperating Profit | ₹475 Cr |
| Other income and charges | |
| Profit before tax | ₹343 Cr |
| Tax | |
| Net profitNet Profit | ₹263 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹4,521 Cr |
| Equity capitalEquity Capital | ₹16 Cr |
| Reserves | ₹2,425 Cr |
| Borrowings | ₹825 Cr |
| Other liabilitiesOther Liabilities | ₹1,255 Cr |
| AssetsTotal Assets | ₹4,521 Cr |
| Fixed assetsFixed Assets | ₹2,335 Cr |
| Capital work in progressCWIP | ₹197 Cr |
| Investments | ₹310 Cr |
| Other assetsOther Assets | ₹1,679 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹441 Cr |
| Investing cash flowCash from Investing Activity | -₹211 Cr |
| Financing cash flowCash from Financing Activity | -₹208 Cr |
| Change in cashNet Cash Flow | ₹22 Cr |
Learn while you research
Academy chapters picked for Jubilant Ingrevia Limited and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 39.8, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read